(Q48587787)

13 February 2018

title

Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis. (English)

1 reference

13 February 2018

relapsing-remitting multiple sclerosis

main subject

0 references

0 references

4

1 reference

13 February 2018

author name string

Martino G

1

1 reference

13 February 2018

Consiglio A

2

1 reference

13 February 2018

Franciotta DM

3

1 reference

13 February 2018

Filippi M

5

1 reference

13 February 2018

Vandenbroeck K

6

1 reference

13 February 2018

Sciacca FL

7

1 reference

13 February 2018

Comi G

8

1 reference

13 February 2018

Grimaldi LM

9

1 reference

13 February 2018

publication date

1 November 1997

1 reference

13 February 2018

Journal of the Neurological Sciences

published in

1 reference

13 February 2018

volume

152

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

51-61

1 reference

13 February 2018

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Tumor Necrosis Factor (TNF) α quantification by ELISA and bioassay: effects of TNFα-soluble TNF receptor (p55) complex dissociation during assay incubations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Undetectable tumor necrosis factor-alpha in spinal fluid from HIV-1-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Tumor necrosis factor identified in multiple sclerosis brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Immunological aspects of demyelinating diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Shedding of tumor necrosis factor receptors by activated human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900142-1

10.1016/S0022-510X(97)00142-1

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018